abrdn Life Sciences Investors
HQL
67 hedge funds and large institutions have $85.1M invested in abrdn Life Sciences Investors in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 13 reducing their positions, and 8 closing their positions.
131% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 13
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
0% more funds holding
Funds holding: 67 → 67 (0)
1.34% less ownership
Funds ownership: 18.14% → 16.8% (-1.3%)
10% less capital invested
Capital invested by funds: $94.2M → $85.1M (-$9.18M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$653K |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$516K |
| 3 |
LPL Financial
San Diego,
California
|
+$508K |
| 4 |
OFA
Oak Family Advisors
Chicago,
Illinois
|
+$359K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$357K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Matisse Capital
Portland,
Oregon
|
-$3.54M |
| 2 |
1CP
1607 Capital Partners
Richmond,
Virginia
|
-$2.16M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$1.75M |
| 4 |
SFS
Shaker Financial Services
Arlington,
Virginia
|
-$1.29M |
| 5 |
Lazard Asset Management
New York
|
-$409K |
HQL Hedge Fund Activity: Q3 2021 in Review
67 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2021, worth a combined $85.1M — down 9.7% from $94.2M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new HQL positions and 8 closed out — a net gain of 2 holders — while 30 added to existing stakes and 13 trimmed.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $653K. The largest seller was Matisse Capital, exiting entirely with an estimated $3.54M sold.
- 67 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $85.1M of abrdn Life Sciences Investors stock for Q3 2021, down 9.7% quarter-over-quarter.
- 10 funds opened new abrdn Life Sciences Investors positions in Q3 2021 and 8 closed out, a net change of +2 holders.
- The largest abrdn Life Sciences Investors buyer in Q3 2021 was Bank of Montreal, an estimated $653K added.
- The largest abrdn Life Sciences Investors seller in Q3 2021 was Matisse Capital, an estimated $3.54M sold.
Based on aggregated 13F filings for Q3 2021.